With Positive Phase II Dry Eye Data in Hand, What’s Next for Aldeyra’s Promising Pipeline?

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 198″]

Aldeyra CEO and president Todd Brady shares the podcast mike with Dave McMullin, the former Shire executive who recently joined as senior vice president of corporate development and strategy. Together, the pair discuss the company’s positive Phase II test results for topical ocular reproxalap in patients with dry eye disease. They also speak about Aldeyra’s promising pipeline.